Akso Health Group

Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Beijing, China.

Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.

QINGDAO CHINA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ: AHG) ( "Akso Health," "the Company," or "we") today announced its plan to make an equity investment in Deyihui, an online clinic based in China.

AHG Announces Plan to Acquire Online Clinic

BEIJING, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ: AHG) (“Akso Health” the “Company” or “we”), announced today that on October 11, 2023, it received a letter from the Nasdaq Listing Qualifications Department notifying the Company that it had regained compliance with the minimum bid price requirement.

Akso Health Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement

BEIJING, April 27, 2023 (GLOBE NEWSWIRE) --  Akso Health Group (NASDAQ: AHG) (“Akso Health” the “Company” or “we”), today announced that the Company has received a notification letter  from the Nasdaq Stock Market LLC (“Nasdaq”) on April 25, 2023, notifying the Company that it has been granted an additional 180-day compliance period, or until October 23, 2023 to regain compliance with Nasdaq's minimum bid price rule.

Akso Health Group Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

BEIJING, March 06, 2023 (GLOBE NEWSWIRE) -- Akso Health Group (NASDAQ: AHG) ("Akso Health" the "Company" or “we”), today announced that on February 28, 2023, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Global Market set forth in Nasdaq Listing Rule 5450(b)(1)(A) (the "Nasdaq Listing Rules"). The Nasdaq Listing Rules requires listed companies to maintain stockholders' equity of at least $10 million. The Company's Form 6-K filed with the Securities and Exchange Commission on February 16, 2023 reported stockholders' equity of approximately $9.9 million as of September 30, 2022, which is below the minimum stockholders' equity required for continued listing pursuant to the Nasdaq Listing Rules.

Akso Health Group Received Nasdaq Notification Letter Regarding Stockholders' Equity Deficiency

BEIJING , Oct. 28, 2022 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" the "Company" or "we"), today announced that the Company has received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 26, 2022, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.

Akso Health Group Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

BEIJING , Aug. 17, 2022 /PRNewswire/ -- Akso Health Group. (NASDAQ: AHG) ("Akso Health" the "Company" or "we"), today announced that the Company received a written notification (the "Notification") from the Nasdaq Stock Market LLC ("Nasdaq") on August 16, 2022, indicating the Company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rules 5250(c)(1) since the Company has not yet filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2022 (the "Filing") with the Securities and Exchange Commission (the "SEC").

News for Akso Health Group Stock (AHG)